{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:46:39Z","timestamp":1793069199024,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.encep.2022.08.011","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T20:15:43Z","timestamp":1682194543000},"page":"304-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combinaison de la k\u00e9tamine et de l\u2019esk\u00e9tamine avec la th\u00e9rapie d\u2019exposition avec pr\u00e9vention de la r\u00e9ponse (EPR) dans le trouble obsessionnel-compulsif"],"prefix":"10.1016","volume":"49","author":[{"given":"Hugo","family":"Bottemanne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Najar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Delaigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Serresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Mouchabac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.encep.2022.08.011_bib0240","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.2200","article-title":"Obsessive-compulsive disorder: advances in diagnosis and treatment","volume":"317","author":"Hirschtritt","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.encep.2022.08.011_bib0245","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/da.22232","article-title":"Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials","volume":"31","author":"Romanelli","year":"2014","journal-title":"Depress Anxiety"},{"issue":"8","key":"10.1016\/j.encep.2022.08.011_bib0250","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.cpr.2008.07.001","article-title":"Psychological treatment of obsessive-compulsive disorder: a meta-analysis","volume":"28","author":"Rosa-Alc\u00e1zar","year":"2008","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"10.1016\/j.encep.2022.08.011_bib0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/eb-2017-102718","article-title":"A systematic review of network meta-analyses for pharmacological treatment of common mental disorders","volume":"21","author":"Williams","year":"2018","journal-title":"Evid Based Ment Health"},{"issue":"1","key":"10.1016\/j.encep.2022.08.011_bib0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","article-title":"Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder","volume":"162","author":"Foa","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2022.08.011_bib0265","doi-asserted-by":"crossref","first-page":"112821","DOI":"10.1016\/j.psychres.2020.112821","article-title":"The heterogeneous course of OCD - A scoping review on the variety of definitions","volume":"285","author":"K\u00fchne","year":"2020","journal-title":"Psychiatry Res"},{"issue":"27","key":"10.1016\/j.encep.2022.08.011_bib0270","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007397","article-title":"The cost-effectiveness of deep brain stimulation for patients with treatment-resistant obsessive-compulsive disorder","volume":"96","author":"Moon","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.encep.2022.08.011_bib0275","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-019-05397-8","article-title":"Ketamine induces immediate and delayed alterations of OCD-like behavior","volume":"237","author":"Thompson","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.encep.2022.08.011_bib0280","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2022.08.011_bib0285","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4088\/JCP.10l06653","article-title":"Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder","volume":"72","author":"Rodriguez","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2022.08.011_bib0290","doi-asserted-by":"crossref","first-page":"102183","DOI":"10.1016\/j.ajp.2020.102183","article-title":"Clinical utility of repeated intravenous ketamine treatment for resistant obsessive-compulsive disorder","volume":"52","author":"Sharma","year":"2020","journal-title":"Asian J Psychiatr"},{"issue":"11","key":"10.1016\/j.encep.2022.08.011_bib0295","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.biopsych.2012.05.028","article-title":"Effects of ketamine in treatment-refractory obsessive-compulsive disorder","volume":"72","author":"Bloch","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2022.08.011_bib0300","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/JCP.0000000000001179","article-title":"Cannabinoid augmentation of exposure-based psychotherapy for obsessive-compulsive disorder","volume":"40","author":"Kayser","year":"2020","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.encep.2022.08.011_bib0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-0035-1569371","article-title":"Does pregnenolone enhance exposure therapy in obsessive-compulsive disorder? A pilot, interim report of a randomized, placebo-controlled, double-blind study","volume":"49","author":"Kellner","year":"2016","journal-title":"Pharmacopsychiatry"},{"issue":"11","key":"10.1016\/j.encep.2022.08.011_bib0310","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamapsychiatry.2022.2996","article-title":"Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression","volume":"79","author":"Bottemanne","year":"2022","journal-title":"JAMA psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2022.08.011_bib0315","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.encep.2021.02.017","article-title":"[Augmented psychotherapy with rTMS in functional neurological disorder]","volume":"48","author":"Bottemanne","year":"2022","journal-title":"Encephale"},{"key":"10.1016\/j.encep.2022.08.011_bib0320","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pnpbp.2016.04.003","article-title":"Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders","volume":"70","author":"Choi","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2022.08.011_bib0325","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.encep.2020.08.006","article-title":"[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]","volume":"47","author":"Bottemanne","year":"2021","journal-title":"Encephale"},{"issue":"2","key":"10.1016\/j.encep.2022.08.011_bib0330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/02791072.2019.1587556","article-title":"Ketamine assisted psychotherapy (KAP): patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy","volume":"51","author":"Dore","year":"2019","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.encep.2022.08.011_bib0335","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4088\/JCP.15l10138","article-title":"Can exposure-based CBT extend IV ketamine's effects in obsessive-compulsive disorder? An open-label trial","volume":"77","author":"Rodriguez","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"10\u201312","key":"10.1016\/j.encep.2022.08.011_bib0340","first-page":"9","article-title":"Ketamine augmentation of exposure response prevention therapy for obsessive compulsive disorder","volume":"18","author":"Bottemanne","year":"2021","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.encep.2022.08.011_bib0345","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.encep.2022.08.011_bib0350","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/npp.2016.186","article-title":"Ketamine treatment and global brain connectivity in major depression","volume":"42","author":"Abdallah","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.encep.2022.08.011_bib0355","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/jamapsychiatry.2016.3955","article-title":"D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: a systematic review and meta-analysis of individual participant data","volume":"74","author":"Mataix-Cols","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.encep.2022.08.011_bib0360","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/da.22132","article-title":"Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy","volume":"30","author":"Farrell","year":"2013","journal-title":"Depress Anxiety"},{"issue":"3","key":"10.1016\/j.encep.2022.08.011_bib0365","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1176\/appi.ajp.2007.07121871","article-title":"Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder","volume":"165","author":"Rothbaum","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2022.08.011_bib0370","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/JCP.0000000000000659","article-title":"Intranasal ketamine and cognitive-behavioral therapy for treatment-refractory obsessive-compulsive disorder","volume":"37","author":"Adams","year":"2017","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.encep.2022.08.011_bib0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pscychresns.2015.06.001","article-title":"In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: proof of concept","volume":"233","author":"Rodriguez","year":"2015","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.encep.2022.08.011_bib0380","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bja.2018.03.011","article-title":"Subanaesthetic ketamine and altered states of consciousness in humans","volume":"121","author":"Vlisides","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.encep.2022.08.011_bib0385","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jad.2018.02.049","article-title":"Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression","volume":"232","author":"Niciu","year":"2018","journal-title":"J Affect Disord"},{"key":"10.1016\/j.encep.2022.08.011_bib0390","series-title":"Ketamine for depression: The role of dissociative effects (Thesis in cognitive neuroscience","author":"Brostr\u00f6m","year":"2020"},{"issue":"1","key":"10.1016\/j.encep.2022.08.011_bib0395","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1038\/s41467-020-20190-4","article-title":"The role of dissociation in ketamine's antidepressant effects","volume":"11","author":"Ballard","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.encep.2022.08.011_bib0400","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.biopsych.2018.09.004","article-title":"Leveraging neuroplasticity to enhance adaptive learning: the potential for synergistic somatic-behavioral treatment combinations to improve clinical outcomes in depression","volume":"85","author":"Wilkinson","year":"2019","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.encep.2022.08.011_bib0405","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.janxdis.2014.06.001","article-title":"The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder","volume":"28","author":"Williams","year":"2014","journal-title":"J Anxiety Disord"},{"issue":"9","key":"10.1016\/j.encep.2022.08.011_bib0410","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/npp.2015.59","article-title":"Distinct neuropsychological mechanisms may explain delayed- versus rapid-onset antidepressant efficacy","volume":"40","author":"Stuart","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.encep.2022.08.011_bib0415","doi-asserted-by":"crossref","first-page":"103730","DOI":"10.1016\/j.brat.2020.103730","article-title":"Augmenting exposure therapy with pre-extinction fear memory reactivation and deepened extinction: a randomized controlled trial","volume":"135","author":"Lancaster","year":"2020","journal-title":"Behav Res Ther"},{"issue":"6","key":"10.1016\/j.encep.2022.08.011_bib0420","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/jamapsychiatry.2013.914","article-title":"Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit","volume":"70","author":"Milad","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2022.08.011_bib0425","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1038\/s41467-019-13162-w","article-title":"Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories","volume":"10","author":"Das","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.encep.2022.08.011_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.026","article-title":"Ketamine accelerates fear extinction via mTORC1\u00a0signaling","volume":"100","author":"Girgenti","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"12","key":"10.1016\/j.encep.2022.08.011_bib0435","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4088\/JCP.v66n1209","article-title":"Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale","volume":"66","author":"Tolin","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.encep.2022.08.011_bib0440","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/JCP.0000000000001281","article-title":"Ketamine and Monoamine oxidase inhibitor combination: utility, safety, efficacy?","volume":"40","author":"Bottemanne","year":"2020","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2022.08.011_bib0445","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4088\/JCP.16cr11234","article-title":"Challenges in testing intranasal ketamine in obsessive-compulsive disorder","volume":"78","author":"Rodriguez","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2022.08.011_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bjc.12188","article-title":"Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting","volume":"58","author":"Rector","year":"2019","journal-title":"Br J Clin Psychol"},{"issue":"41","key":"10.1016\/j.encep.2022.08.011_bib0455","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.2174\/0929867325666171222163645","article-title":"A Systematic review of evidence-based treatment strategies for obsessive- compulsive disorder resistant to first-line pharmacotherapy","volume":"25","author":"Albert","year":"2018","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.encep.2022.08.011_bib0460","doi-asserted-by":"crossref","first-page":"e65088","DOI":"10.1371\/journal.pone.0065088","article-title":"Ketamine effects on memory reconsolidation favor a learning model of delusions","volume":"8","author":"Corlett","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.encep.2022.08.011_bib0465","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.encep.2022.08.011_bib0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1176\/appi.psychotherapy.2010.64.1.39","article-title":"When exposures go wrong: troubleshooting guidelines for managing difficult scenarios that arise in exposure-based treatment for obsessive-compulsive disorder","volume":"64","author":"Pence","year":"2010","journal-title":"Am J Psychother"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700622001804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700622001804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:43:23Z","timestamp":1757958203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700622001804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0013700622001804"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2022.08.011","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinaison de la k\u00e9tamine et de l\u2019esk\u00e9tamine avec la th\u00e9rapie d\u2019exposition avec pr\u00e9vention de la r\u00e9ponse (EPR) dans le trouble obsessionnel-compulsif","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2022.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}